For: | Qi HL, Zhuang BJ, Li CS, Liu QY. Peri-operative use of sorafenib in liver transplantation: A time-to-event meta-analysis. World J Gastroenterol 2015; 21(5): 1636-1640 [PMID: 25663784 DOI: 10.3748/wjg.v21.i5.1636] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i5/1636.htm |
Number | Citing Articles |
1 |
Marta Guerrero, Gustavo Ferrín, Manuel Rodríguez-Perálvarez, Sandra González-Rubio, Marina Sánchez-Frías, Víctor Amado, Juan C. Pozo, Antonio Poyato, Rubén Ciria, María D. Ayllón, Pilar Barrera, José L. Montero, Manuel de la Mata. mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence. International Journal of Molecular Sciences 2019; 20(2): 336 doi: 10.3390/ijms20020336
|
2 |
Xiao Xu, Jun Chen, Qiang Wei, Zhi-Kun Liu, Zhe Yang, Ming Zhang, Guo-Ying Wang, Jie Gao, Zhao-Xu Yang, Wen-Yuan Guo, Tong-Hai Xing, Zhou Shao, Qin-Fen Xie, Shu-Sen Zheng. Clinical practice guidelines on liver transplantation for hepatocellular carcinoma in China (2018 edition). Hepatobiliary & Pancreatic Diseases International 2019; 18(4): 307 doi: 10.1016/j.hbpd.2019.06.010
|
3 |
Yu-Qing Yang, Zhen-Yu Wen, Xiao-Yan Liu, Zhen-Hu Ma, Yan-E Liu, Xue-Ying Cao, Li Hou, Hui Xie. Current status and prospect of treatments for recurrent hepatocellular carcinoma. World Journal of Hepatology 2023; 15(2): 129-150 doi: 10.4254/wjh.v15.i2.129
|
4 |
Lei Zhu, Jie Zhang, Hongxia Zhou, Guanqi Zhang, Bin Wang, Haolong Qi. Clinical role of the long non‑coding RNA, EGFR‑AS1, in patients with cancer: A systematic review and meta‑analysis. Oncology Letters 2024; 27(5) doi: 10.3892/ol.2024.14332
|